Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment

Mogrify, Astellas Pharma partner for sensorineural hearing loss treatment

Source: 
Pharmaceutical Business Review
snippet: 

UK-based Mogrify has collaborated with Astellas Pharma to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss.